vs
Side-by-side financial comparison of KFORCE INC (KFRC) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
KFORCE INC is the larger business by last-quarter revenue ($330.4M vs $250.2M, roughly 1.3× USANA HEALTH SCIENCES INC). USANA HEALTH SCIENCES INC runs the higher net margin — 3.0% vs 2.4%, a 0.6% gap on every dollar of revenue. On growth, KFORCE INC posted the faster year-over-year revenue change (0.1% vs -3.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs -3.7%).
Kforce Inc. is a professional staffing and solutions firm headquartered in the United States. It provides skilled professional placements and specialized workforce solutions primarily across technology, finance & accounting, and healthcare segments, serving a wide range of mid-sized to large enterprise clients nationwide.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
KFRC vs USNA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $330.4M | $250.2M |
| Net Profit | $7.9M | $7.5M |
| Gross Margin | 27.3% | 76.2% |
| Operating Margin | 3.6% | 5.5% |
| Net Margin | 2.4% | 3.0% |
| Revenue YoY | 0.1% | -3.0% |
| Net Profit YoY | -2.7% | -20.0% |
| EPS (diluted) | $0.46 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $330.4M | $250.2M | ||
| Q4 25 | $332.0M | $226.2M | ||
| Q3 25 | $332.6M | $213.7M | ||
| Q2 25 | $334.3M | $235.8M | ||
| Q1 25 | $330.0M | $249.5M | ||
| Q4 24 | $343.8M | $213.6M | ||
| Q3 24 | $353.3M | $200.2M | ||
| Q2 24 | $356.3M | — |
| Q1 26 | $7.9M | $7.5M | ||
| Q4 25 | $5.2M | $180.0K | ||
| Q3 25 | $11.1M | $-6.5M | ||
| Q2 25 | $10.4M | $9.7M | ||
| Q1 25 | $8.1M | $9.4M | ||
| Q4 24 | $11.1M | $4.5M | ||
| Q3 24 | $14.2M | $10.6M | ||
| Q2 24 | $14.2M | — |
| Q1 26 | 27.3% | 76.2% | ||
| Q4 25 | 27.2% | 78.2% | ||
| Q3 25 | 27.7% | 77.2% | ||
| Q2 25 | 27.1% | 78.7% | ||
| Q1 25 | 26.7% | 79.0% | ||
| Q4 24 | 27.0% | 82.0% | ||
| Q3 24 | 27.9% | 80.4% | ||
| Q2 24 | 27.8% | — |
| Q1 26 | 3.6% | 5.5% | ||
| Q4 25 | 2.6% | 1.7% | ||
| Q3 25 | 4.5% | 0.6% | ||
| Q2 25 | 4.5% | 7.1% | ||
| Q1 25 | 3.5% | 6.3% | ||
| Q4 24 | 4.5% | 3.8% | ||
| Q3 24 | 5.3% | 7.8% | ||
| Q2 24 | 5.5% | — |
| Q1 26 | 2.4% | 3.0% | ||
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 3.3% | -3.1% | ||
| Q2 25 | 3.1% | 4.1% | ||
| Q1 25 | 2.5% | 3.8% | ||
| Q4 24 | 3.2% | 2.1% | ||
| Q3 24 | 4.0% | 5.3% | ||
| Q2 24 | 4.0% | — |
| Q1 26 | $0.46 | $0.41 | ||
| Q4 25 | $0.29 | $-0.10 | ||
| Q3 25 | $0.63 | $-0.36 | ||
| Q2 25 | $0.59 | $0.52 | ||
| Q1 25 | $0.45 | $0.49 | ||
| Q4 24 | $0.60 | $0.23 | ||
| Q3 24 | $0.75 | $0.56 | ||
| Q2 24 | $0.75 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $117.4M | — |
| Total Assets | $384.8M | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.3M | $162.8M | ||
| Q4 25 | $2.1M | $158.4M | ||
| Q3 25 | $1.3M | $145.3M | ||
| Q2 25 | $2.5M | $151.3M | ||
| Q1 25 | $444.0K | $179.6M | ||
| Q4 24 | $349.0K | $181.8M | ||
| Q3 24 | $127.0K | $364.9M | ||
| Q2 24 | $110.0K | — |
| Q1 26 | $117.4M | — | ||
| Q4 25 | $124.6M | — | ||
| Q3 25 | $132.1M | $528.1M | ||
| Q2 25 | $134.4M | $531.1M | ||
| Q1 25 | $138.0M | $529.8M | ||
| Q4 24 | $154.6M | $532.1M | ||
| Q3 24 | $167.4M | $533.1M | ||
| Q2 24 | $166.6M | — |
| Q1 26 | $384.8M | $739.0M | ||
| Q4 25 | $365.6M | $742.9M | ||
| Q3 25 | $374.2M | $726.6M | ||
| Q2 25 | $373.6M | $734.5M | ||
| Q1 25 | $368.2M | $746.6M | ||
| Q4 24 | $357.8M | $748.2M | ||
| Q3 24 | $369.9M | $671.3M | ||
| Q2 24 | $362.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $-7.4M | — |
| FCF MarginFCF / Revenue | -2.2% | — |
| Capex IntensityCapex / Revenue | 1.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $19.7M | — | ||
| Q3 25 | $23.3M | $-2.0M | ||
| Q2 25 | $18.4M | $12.2M | ||
| Q1 25 | $249.0K | $15.5M | ||
| Q4 24 | $21.8M | $5.8M | ||
| Q3 24 | $31.0M | $29.5M | ||
| Q2 24 | $20.9M | — |
| Q1 26 | $-7.4M | — | ||
| Q4 25 | $16.7M | — | ||
| Q3 25 | $19.8M | $-5.2M | ||
| Q2 25 | $14.2M | $7.2M | ||
| Q1 25 | $-3.9M | $12.7M | ||
| Q4 24 | $20.9M | $4.0M | ||
| Q3 24 | $27.5M | $27.1M | ||
| Q2 24 | $17.8M | — |
| Q1 26 | -2.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 6.0% | -2.4% | ||
| Q2 25 | 4.3% | 3.0% | ||
| Q1 25 | -1.2% | 5.1% | ||
| Q4 24 | 6.1% | 1.9% | ||
| Q3 24 | 7.8% | 13.6% | ||
| Q2 24 | 5.0% | — |
| Q1 26 | 1.0% | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.1% | 1.5% | ||
| Q2 25 | 1.2% | 2.1% | ||
| Q1 25 | 1.3% | 1.1% | ||
| Q4 24 | 0.3% | 0.8% | ||
| Q3 24 | 1.0% | 1.2% | ||
| Q2 24 | 0.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.82× | — | ||
| Q3 25 | 2.11× | — | ||
| Q2 25 | 1.76× | 1.27× | ||
| Q1 25 | 0.03× | 1.65× | ||
| Q4 24 | 1.97× | 1.29× | ||
| Q3 24 | 2.18× | 2.78× | ||
| Q2 24 | 1.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
